Total Funding
81
45
Total FundingSeries A raised
Growth Score
-10 pts
Heat Score
-20 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
42378
Etiome, a company redefining how we detect and preempt disease progression.
- Noubar Afeyan: Co-FounderPast Role: Tessera Therapeutics, Co-Founder & Board Member
Jean Lachowicz: Cheif Scientific OfficerPast Role: Schrödinger, SVP and Chief Development Scientist
About the Company
Etiome is disrupting the progression of disease before it becomes debilitating and irreversible by developing and deploying Biostaged Medicines.
